Knight Therapeutics | GUD - Ordinary Share Capital

Stock Price
6.14
Daily Change
0.04 0.66%
Monthly
-4.06%
Yearly
-0.49%
Q1 Forecast
5.95

Knight Therapeutics reported CAD99.68M in Ordinary Share Capital for its fiscal quarter ending in September of 2025.





Ordinary Share Capital Change Date
Acasti Pharma USD 1000 261.04M Dec/2024
Akebia Therapeutics USD 2K 0 Mar/2025
Alaunos Therapeutics USD 2.21M 2.2M Sep/2025
Aurora Cannabis CAD 6.98B 907K Dec/2024
Canopy Growth CAD 332.38M 127.23M Sep/2025
Cronos Group USD 382.89M 286.14M Sep/2025
Dianthus Therapeutics USD 42.85M 42.82M Sep/2025
Ionis Pharmaceuticals USD 161.97M 836K Dec/2025
IQVIA Holdings USD 169.6M 700K Dec/2025
Knight Therapeutics CAD 99.68M 24.66K Sep/2025
Moderna USD 391M 2M Sep/2025
Omeros USD 611K 17K Dec/2023
Organigram Holdings CAD 134.46M 438.86K Sep/2025
Organon & Co USD 259.98M 18K Sep/2025
Revvity USD 113.38M 2.7M Dec/2025
Tectonic Therapeutic USD 14.86M 111.83K Dec/2024
Tilray USD 1.06B 86.93M Mar/2025
Viatris USD 1.16B 6.55M Sep/2025
Xeris Pharmaceuticals USD 165.53M 165.51M Sep/2025